Choosing The Right CDMO For Late-Phase Clinical Trials
For many pharmaceutical companies that do not have their own facilities, choosing the right partner for late-phase clinical trials and commercial production is a critical aspect in the management of parenteral products.
Join Christy Eatmon, Global SME, Sterile Drug Products at Thermo Fisher Scientific, where she will lead a webcast that will offer insight into the importance of looking for a partner with extensive experience in the parenteral arena.
Live: Wednesday, Oct. 30, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
On demand available after final airing Oct. 30, 2020